Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.140
0.00 (0.00%)
May 20, 2026, 4:00 PM EDT - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $48.64 million as of May 20, 2026. Its market cap has increased by 19.02% in one year.
Market Cap
48.64M
Enterprise Value
46.71M
1-Year Change
19.02%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $48.64M, an increase of 2,636.18%. That is a compound annual growth rate of 151.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 48.64M | -17.44% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 54.45M |
| Instil Bio | 54.32M |
| KALA BIO | 53.35M |
| iBio, Inc. | 53.13M |
| MiNK Therapeutics | 52.16M |
| Radiopharm Theranostics | 50.67M |
| Xilio Therapeutics | 50.55M |
| aTyr Pharma | 48.87M |